성기웅 교수
#신경모세포종#뇌종양#Wilms종양#소아암#조혈모세포이식#EBS명의
|
학력
2002.08 서울대학교 대학원 의학과 (박사)
1997.02 서울대학교 대학원 의학과 (석사)
1988.02 서울대학교 의과대학 졸업 (의학사)
1983.02 서울대학교 의예과 수료
1997.02 서울대학교 대학원 의학과 (석사)
1988.02 서울대학교 의과대학 졸업 (의학사)
1983.02 서울대학교 의예과 수료
경력
2017.04 ~현재 성균관의대 소아청소년과학교실 주임교수
2017.04 ~현재 삼성서울병원 소아청소년과 과장
2013.0801 ~현재 삼성서울병원 인력양성센터장
2009.03 ~현재 성균관의대 삼성서울병원 교수
2009.0901 ~ 2013.07 성균관의대 삼성서울병원 소아암센터장
2002.10 ~ 2009.02 성균관의대 삼성서울병원 부교수
2002.08 ~ 2004.03 미국 인디아나의대 암센터 연수
1999.03 ~ 2002.09 성균관의대 삼성서울병원 소아과 조교수
1998.03 ~ 1999.02 성균관의대 삼성서울병원 소아과 혈액종양 전문의
1997.03 ~ 1998.02 성균관의대 삼성서울병원 소아과 혈액종양 전임의
1996.03 ~ 1997.02 서울대학교병원 소아과 혈액종양 전임의
1996.02 소아과 전문의 자격 취득
1992.03 ~ 1996.02 서울대학교병원 소아과 레지던트과정 수료
1991.05 ~ 1992.02 서울대학교병원 인턴과정 수료
2017.04 ~현재 삼성서울병원 소아청소년과 과장
2013.0801 ~현재 삼성서울병원 인력양성센터장
2009.03 ~현재 성균관의대 삼성서울병원 교수
2009.0901 ~ 2013.07 성균관의대 삼성서울병원 소아암센터장
2002.10 ~ 2009.02 성균관의대 삼성서울병원 부교수
2002.08 ~ 2004.03 미국 인디아나의대 암센터 연수
1999.03 ~ 2002.09 성균관의대 삼성서울병원 소아과 조교수
1998.03 ~ 1999.02 성균관의대 삼성서울병원 소아과 혈액종양 전문의
1997.03 ~ 1998.02 성균관의대 삼성서울병원 소아과 혈액종양 전임의
1996.03 ~ 1997.02 서울대학교병원 소아과 혈액종양 전임의
1996.02 소아과 전문의 자격 취득
1992.03 ~ 1996.02 서울대학교병원 소아과 레지던트과정 수료
1991.05 ~ 1992.02 서울대학교병원 인턴과정 수료
논문
J CANCER SURVIV 2019 10.1007/s11764-019-00825-2
Influenza vaccination in caregivers of childhood cancer survivors
Cho1, IY; Yoo, JE; Ko, H; Shin, DW; Lee, JW; Baek, HJ; Chung, NG; Sung, KW; Song, YM
J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e254
Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
Seo1, E; Kim, JS; Ma, YE; Cho, HW; Ju, HY; Lee, SH; Lee, JW; Yoo, KH; Sung, KW; Koo, HH
BONE MARROW TRANSPL 2019 10.1038/s41409-019-0492-6
Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)
Yoon1, JH; Yoo, KH; Sung, KW; Jung, CW; Kim, JS; Hahn, SM; Kang, HJ; Lee, JH; Im, HJ; Ahn, JS; Kook, H; Cho, B; Lee, JW
PEDIATR TRANSPLANT 2019 10.1111/petr.13397
Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate- or high-risk cytogenetics
Park1, EG; Yi, ES; Choi, YB; Sung, KW; Koo, HH; Yoo, KH
CELL PROLIFERAT 2019 10.1111/cpr.12577
Inhibition of N-myc expression sensitizes human neuroblastoma IMR-32 cells expressing caspase-8 to TRAIL
Lee1, MW; Kim, DS; Kim, HR; Park, HJ; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
LEUKEMIA 2019 10.1038/s41375-018-0373-9
Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
Lee1, MW; Ryu, S; Kim, DS; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e46
Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
Choi1, YB; Lee, JW; Sung, KW; Koo, HH; Kim, HJ; Yoo, KH
TRANSL ONCOL 2018 10.1016/j.tranon.2018.08.013
Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors
Lee1, B; Lee, JW; Shim, JH; Joung, JG; Yun, JW; Bae, JS; Shin, HT; Sung, KW; Park, WY
J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e260
Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
Cho1, HW; Lee, JW; Ma, Y; Yoo, KH; Sung, KW; Koo, HH
PEDIATR BLOOD CANCER 2018 10.1002/pbc.27257
Clinical significance of MYCN amplification in patients with high-risk neuroblastoma
Lee1, JW; Son, MH; Cho, HW; Ma, YE; Yoo, KH; Sung, KW; Koo, HH
J CLIN IMMUNOL 2018 10.1007/s10875-018-0542-7
Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center
Yi1, ES; Choi, YB; Lee, NH; Lee, JW; Sung, KW; Koo, HH; Kang, ES; Kim, YJ; Yoo, KH
CANCER RES TREAT 2018 10.4143/crt.2017.283
NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia
Yi1, ES; Choi, YB; Choi, R; Lee, NH; Lee, JW; Yoo, KH; Sung, KW; Lee, SY; Koo, HH
STEM CELL REV 2018 10.1007/s12015-018-9806-0
Human Adipose Tissue Stem Cells Promote the Growth of Acute Lymphoblastic Leukemia Cells in NOD/SCID Mice
Lee1, MW; Park, YJ; Kim, DS; Park, HJ; Jung, HL; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
TRANSPL INFECT DIS 2018 10.1111/tid.12885
Prospective monitoring of adenovirus infection and type analysis after allogeneic hematopoietic cell transplantation: A single-center study in Korea
Kang1, JM; Park, KS; Kim, JM; Huh, HJ; Ki, CS; Lee, NY; Yoo, KH; Sung, KW; Koo, HH; Kim, YJ
PEDIATR TRANSPLANT 2018 10.1111/petr.13127
Multimodal treatment including tandem high-dose chemotherapy and autologous stem cell transplantation in children with anaplastic ependymomas
Lee1, JW; Lim, DH; Sung, KW; Lee, HJ; Yi, ES; Yoo, KH; Koo, HH; Suh, YL; Shin, HJ
J KOREAN NEUROSURG SOC 2018 10.3340/jkns.2018.0039
Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Children with Brain Tumors : Review of Single Center Experience
Sung1, KW; Lim, DH; Shin, HJ
STEM CELL REV 2018 10.1007/s12015-017-9793-6
Involvement of TLR3-Dependent PGES Expression in Immunosuppression by Human Bone Marrow Mesenchymal Stem Cells
Kim1, DS; Lee, WH; Lee, MW; Park, HJ; Jang, IK; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
CANCER LETT 2018 10.1016/j.canlet.2018.01.020
Anti-leukemic effects of PPAR gamma ligands
Ryu1, S; Kim, DS; Lee, MW; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
EBioMedicine 2018 10.1016/j.ebiom.2018.01.002
Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-gamma
Kim1, DS; Jang, IK; Lee, MW; Ko, YJ; Lee, DH; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
ONCOTARGET 2017 10.18632/oncotarget.17500
ARID1B alterations identify aggressive tumors in neuroblastoma
Lee1, SH; Kim, JS; Zheng, SY; Huse, JT; Bae, JS; Lee, JW; Yoo, KH; Koo, HH; Kyung, S; Park, WY; Sung, KW
Influenza vaccination in caregivers of childhood cancer survivors
Cho1, IY; Yoo, JE; Ko, H; Shin, DW; Lee, JW; Baek, HJ; Chung, NG; Sung, KW; Song, YM
J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e254
Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
Seo1, E; Kim, JS; Ma, YE; Cho, HW; Ju, HY; Lee, SH; Lee, JW; Yoo, KH; Sung, KW; Koo, HH
BONE MARROW TRANSPL 2019 10.1038/s41409-019-0492-6
Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)
Yoon1, JH; Yoo, KH; Sung, KW; Jung, CW; Kim, JS; Hahn, SM; Kang, HJ; Lee, JH; Im, HJ; Ahn, JS; Kook, H; Cho, B; Lee, JW
PEDIATR TRANSPLANT 2019 10.1111/petr.13397
Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate- or high-risk cytogenetics
Park1, EG; Yi, ES; Choi, YB; Sung, KW; Koo, HH; Yoo, KH
CELL PROLIFERAT 2019 10.1111/cpr.12577
Inhibition of N-myc expression sensitizes human neuroblastoma IMR-32 cells expressing caspase-8 to TRAIL
Lee1, MW; Kim, DS; Kim, HR; Park, HJ; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
LEUKEMIA 2019 10.1038/s41375-018-0373-9
Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
Lee1, MW; Ryu, S; Kim, DS; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e46
Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
Choi1, YB; Lee, JW; Sung, KW; Koo, HH; Kim, HJ; Yoo, KH
TRANSL ONCOL 2018 10.1016/j.tranon.2018.08.013
Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors
Lee1, B; Lee, JW; Shim, JH; Joung, JG; Yun, JW; Bae, JS; Shin, HT; Sung, KW; Park, WY
J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e260
Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
Cho1, HW; Lee, JW; Ma, Y; Yoo, KH; Sung, KW; Koo, HH
PEDIATR BLOOD CANCER 2018 10.1002/pbc.27257
Clinical significance of MYCN amplification in patients with high-risk neuroblastoma
Lee1, JW; Son, MH; Cho, HW; Ma, YE; Yoo, KH; Sung, KW; Koo, HH
J CLIN IMMUNOL 2018 10.1007/s10875-018-0542-7
Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center
Yi1, ES; Choi, YB; Lee, NH; Lee, JW; Sung, KW; Koo, HH; Kang, ES; Kim, YJ; Yoo, KH
CANCER RES TREAT 2018 10.4143/crt.2017.283
NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia
Yi1, ES; Choi, YB; Choi, R; Lee, NH; Lee, JW; Yoo, KH; Sung, KW; Lee, SY; Koo, HH
STEM CELL REV 2018 10.1007/s12015-018-9806-0
Human Adipose Tissue Stem Cells Promote the Growth of Acute Lymphoblastic Leukemia Cells in NOD/SCID Mice
Lee1, MW; Park, YJ; Kim, DS; Park, HJ; Jung, HL; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
TRANSPL INFECT DIS 2018 10.1111/tid.12885
Prospective monitoring of adenovirus infection and type analysis after allogeneic hematopoietic cell transplantation: A single-center study in Korea
Kang1, JM; Park, KS; Kim, JM; Huh, HJ; Ki, CS; Lee, NY; Yoo, KH; Sung, KW; Koo, HH; Kim, YJ
PEDIATR TRANSPLANT 2018 10.1111/petr.13127
Multimodal treatment including tandem high-dose chemotherapy and autologous stem cell transplantation in children with anaplastic ependymomas
Lee1, JW; Lim, DH; Sung, KW; Lee, HJ; Yi, ES; Yoo, KH; Koo, HH; Suh, YL; Shin, HJ
J KOREAN NEUROSURG SOC 2018 10.3340/jkns.2018.0039
Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Children with Brain Tumors : Review of Single Center Experience
Sung1, KW; Lim, DH; Shin, HJ
STEM CELL REV 2018 10.1007/s12015-017-9793-6
Involvement of TLR3-Dependent PGES Expression in Immunosuppression by Human Bone Marrow Mesenchymal Stem Cells
Kim1, DS; Lee, WH; Lee, MW; Park, HJ; Jang, IK; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
CANCER LETT 2018 10.1016/j.canlet.2018.01.020
Anti-leukemic effects of PPAR gamma ligands
Ryu1, S; Kim, DS; Lee, MW; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
EBioMedicine 2018 10.1016/j.ebiom.2018.01.002
Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-gamma
Kim1, DS; Jang, IK; Lee, MW; Ko, YJ; Lee, DH; Lee, JW; Sung, KW; Koo, HH; Yoo, KH
ONCOTARGET 2017 10.18632/oncotarget.17500
ARID1B alterations identify aggressive tumors in neuroblastoma
Lee1, SH; Kim, JS; Zheng, SY; Huse, JT; Bae, JS; Lee, JW; Yoo, KH; Koo, HH; Kyung, S; Park, WY; Sung, KW
저서
저서 내용이 없습니다.
보도자료
"약 없어서 몇달씩 기다렸는데" 소아암 치료 희소식
http://www.tjb.co.kr/sub0301/bodo/view/id/41507/version/1
[양선희의 시시각각] ‘터널’에 갇힌 희귀소아암 환자들
http://news.joins.com/article/20559925
삼성서울병원 소아암센터, 童心과 교감… 삶의 희망 심는다
http://news.kmib.co.kr/article/view.asp?arcid=0007328773
http://www.tjb.co.kr/sub0301/bodo/view/id/41507/version/1
[양선희의 시시각각] ‘터널’에 갇힌 희귀소아암 환자들
http://news.joins.com/article/20559925
삼성서울병원 소아암센터, 童心과 교감… 삶의 희망 심는다
http://news.kmib.co.kr/article/view.asp?arcid=0007328773
포스팅
포스팅 내용이 없습니다.
영상자료
희귀 소아암 환자 '날벼락'…치료약 생산 중단 위기
http://news.jtbc.joins.com/article/article.aspx?news_id=NB11302806&pDate=20160829
http://news.jtbc.joins.com/article/article.aspx?news_id=NB11302806&pDate=20160829
발표자료
발표자료 내용이 없습니다.